The National Science Foundation (NSF) awarded a $951,394 Cooperative Agreement under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program to Ballydel Technologies Inc. for the development of serialized anti-counterfeit labeling technology for pharmaceutical and biological products. The project aims to create a scalable manufacturing process for imprinting covert, encrypted patterns onto labels for individual vaccine vials, incorporating serialized codes to enable traceability and authentication throughout the supply chain. The technology focuses on mitigating the global counterfeit drug market, ensuring the integrity of the vaccine and biologic supply chain. The two-year effort seeks to demonstrate the scalable production of the computationally designed tags, integrate an automated tagging and reading process into drug product manufacturing, and deliver a handheld reader for product authentication at any point in the supply chain.
Generated 3/18/25, 5:00 AM